Drug Profile
Ciclesonide/formoterol
Alternative Names: BY9010/M-1506; Ciclesonide/formoterol fumarate; Formoterol/ciclesonideLatest Information Update: 20 Jul 2023
Price :
$50
*
At a glance
- Originator Nycomed
- Developer Sumitomo Pharma America; Takeda Pharmaceuticals International GmbH
- Class Antiasthmatics; Bronchodilators; Ethanolamines; Pregnenediones; Small molecules
- Mechanism of Action Arachidonic acid inhibitors; Beta 2 adrenergic receptor agonists; Immunosuppressants; Lipocortin synthesis agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 30 Sep 2011 Nycomed has been acquired by Takeda
- 12 Oct 2010 Sepracor is now called Sunovion Pharmaceuticals
- 20 Oct 2009 Sepracor has been acquired by Dainippon Sumitomo Pharma